The observational study proposed by Cold et al. included a nationwide cohort of postmenopausal women diagnosed between 1997 and 2004 with early-stage invasive estrogen receptor-positive nonmetastatic BC who received no treatment or 5 years of adjuvant endocrine therapy. The gene discussed is ESR1; the disease is breast cancer.